Effect of adenovirus and influenza virus infection on obesity.
Life Sci. 2013 Oct 11;93(16):531-5. doi: 10.1016/j.lfs.2013.08.016
Hur SJ1, Kim DH, Chun SC, Lee SK.
Department of Bioresources and Food Science, Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-701, Republic of Korea.
Flu has the following
Vitamin D fights all phases of Influenza
- FACT: Vitamin D PREVENTS Influenza 7X lower risk
- FACT: Vitamin D SUPRESSES Influenza ( Vitamin D Hammer )
- Single dose of 50,000 IU of vitamin D stops Influenza symptoms
- FACT: Vitamin D PREVENTS & SUPRESSES Sepsis which is a rare but deadly consequence of Influenza
- FACT: Vitamin D enhances the activity of vaccines.
- FACT: improves Flu vaccine effectiveness and reduces side effects
- FACT: Vitamin D has virtually no side effects
- but 1 in 300 get people get muscle pain or itching due to lower magnesium levels
- FACT: Vitamin D prevents/suppresses over 120 health problems (left column)
- FACT: Both COVID-19 and Influenza are enveloped viruses
- FACT: Do not take vitamin D if Sarcoidosis, excess Calcium, Chemotherapy
- CONCLUSION To help protect/suppress influenza, take 50,000 IU of Vitamin D once a week
during the flu season if you are an average weight adult
Items in both categories Obesity and Virus are listed here:
- Obesity, Virus, and Vitamin D - many studies
- Recent increases in pediatric endocrine problems may be decreased by Vitamin D – Aug 2022
- Obesity, Hypovitaminosis D, and COVID-19 – April 2022
- Less COVID in Japan than US: less obesity (barely mentions Vitamin D and K) - Feb 2022
- Many people are actively trying to lose weight gained during pandemic - Vitamin D will help
- Higher COVID death rates in more obese counties - Dec 2021
- How obesity reduces the ability of vitamin D to fight health problems such as COVID - Nov 2021
- Co-Epidemic of Obesity and COVID-19 (a co-epidemic of Vitamin D not mentioned) – April 2021
- COVID-19 hospitalizations: 63% associated with diabetes, obesity, hypertension or heart failure – Feb 2021
- Light case of COVID-19 in immunocompromised obese man with many comordities but good level of vitamin D – March 2021
- Obese get less benefit from vaccines: influenza, hepatitis B, rabies and now COVID-19 - March 2021
- 26 health factors increase the risk of COVID-19 – all are proxies for low vitamin D
- Virus (adeno-36) increases Obesity which then increases risk of another virus (Influenza) - Oct 2013
- Increased weight in children 8X more likely for each unit increase in adenovirus (if ignore Vitamin D) – Nov 2019
- 25 year review of Adenovirsus and obesity – 2018
- Adenovirus-36 is strongly associated with Obesity (possibly prevented and treated by Vitamin D)
- Adenovirus-36 association with obesity letter to editor – 2011
- Obesity pandemic since 1975 - is it due to Vitamin D, Magnesium, Iodine, adenovirus, or what
- Low vitamin D then Obesity then adenovirus-36
 Download the PDF from VitaminDWiki
Note: Chart ignores the fact the obesity reduces Vitamin D and that Vitamin D fights influenza
The purpose of this review is to provide an overview of the effects of adenovirus and influenza virus infections on obesity in various experimental models. We reviewed studies that were conducted within the past 10 years and were related to virus infection and obesity prevalence. Here, we discuss a different causal relationship between adenovirus and influenza infections with obesity.
Adenovirus infection can cause obesity, whereas obesity can be a risk factor for increasing influenza virus infection and increases the risk of morbidity and mortality. The prevalence of obesity due to adenovirus infections may be due to an increase in glucose uptake and reduction in lipolysis caused by an increase in corticosterone secretion. Adenovirus infections may lead to increases in appetite by decreasing norepinephrine and leptin levels and also cause immune dysfunction. The relationship between obesity and influenza virus infection could be summarized by the following features: decreases in memory T-cell functionality and interferon (IFN)-α, IFN-β, and IFN-γ mRNA expression, increases in viral titer and infiltration, and impaired dendritic cell function in obese individuals. Moreover, leptin resistance may play an important role in increasing influenza virus infections in obese individuals.
In conclusion, prevention of adenovirus infections could be a good approach for reducing obesity prevalence, and prevention of obesity could reduce influenza virus infections from the point of view of viral infections and obesity.